Delivery Order SPE2DB22D3401-SPE2DB26FT0PT
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,661.45 to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units) under a firm fixed-price contract type. The award, issued on September 25, 2025, with an ultimate completion date of September 26, 2025, represents a competitive, non-set-aside procurement. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $25,616.52 to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count packages). This firm fixed-price delivery order, issued on September 5, 2025, with an ultimate completion date of September 8, 2025, represents a non-competitive award to the established pharmaceutical distributor. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency (DLA) awarded a $3,668.62 delivery order to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units) with an ultimate completion date of June 2, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and designates AmerisourceBergen's Conshohocken, Pennsylvania facility as the place of performance. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units) with a ceiling value of $3,930.74. Issued on October 23, 2025, with an ultimate completion date of October 24, 2025, this firm fixed-price contract represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units) under a firm fixed-price arrangement. The contract, valued at $27,148.14, was competitively awarded without set-aside designation and is scheduled for completion by September 24, 2025. AmerisourceBergen will fulfill this order from its Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency has awarded AmerisourceBergen Drug Corp a delivery order valued at $3,952.59 for Progesterone 200 mg capsules (100-count units) under a firm fixed-price contract. This non-set-aside award, issued on October 30, 2025, with an ultimate completion date of October 31, 2025, represents a routine pharmaceutical procurement supporting federal medical supply needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $4,154.61 to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units). This non-set-aside, competitively awarded contract utilizes firm fixed pricing and has an ultimate completion date of June 20, 2025. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (30-count units) under a firm fixed-price contract with a ceiling value of $7,344.92. The order was competitively awarded without set-aside designation and is scheduled for completion by September 26, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in that same city. This delivery order...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $8,144.39 by the Defense Logistics Agency Medical Supply Chain to supply Progesterone 200 mg capsules (100-count) with an ultimate completion date of September 26, 2025. The contract utilizes a firm fixed price structure with no set-aside designation, indicating it was competitively awarded. The product will be delivered to the company's place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency awarded a delivery order valued at $2,969.07 to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units) under a firm fixed-price contract. The award was made on August 11, 2025, with an ultimate completion date of August 12, 2025, with no set-aside designation applied. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office...
- SPE2DB22D3401Indefinite Delivery Contract
- SPE2DB22D3401-SPE2DB26FT0PTDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $13,653.24 to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units). This firm fixed-price, non-set-aside contract was awarded on November 5, 2025, with an ultimate completion date of November 6, 2025. The pharmaceutical product will be performed and delivered from AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), a comprehensive $999.99 billion pharmaceutical supply vehicle valued through December 2026. As a prime vendor for military healthcare systems, AmerisourceBergen supplies an extensive portfolio of pharmaceutical products and medical commodities to support Department of Defense medical supply needs. The company's federal contract awards demonstrate consistent competitively-awarded success across diverse therapeutic domains, positioning it as a critical distributor for federal medical procurement across military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.7k | 11/5/25 |